The congress represents a unique opportunity to discuss the latest diagnostic, therapeutic, and surgical strategies in the management of patients with colon and rectal cancer. The event, aimed at surgeons, oncologists, radiologists, and multidisciplinary specialists, will cover cutting-edge topics such as the personalization of neoadjuvant therapy, new frontiers in immunotherapy, the role of aspirin in preventing recurrences, multimodal strategies for early rectal cancer, and the optimization of multidisciplinary pathways for colorectal cancer patients. Through plenary sessions, interactive discussions, and innovative case studies, participants will have the opportunity to explore personalized approaches based on the most recent evidence and international clinical experiences.